•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Starboard seeks probe after former Pfizer execs pull support for its campaign
Pfizer Skids After Former Execs Flip On Activist Investor, Siding With CEO Albert Bourla
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
Pfizer's stock dips after two former execs say they won't support Starboard, offer backing for CEO Albert Bourla
Pfizer's TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
Pfizer's cancer drug combo improves overall survival in late-stage study
2 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Former Pfizer executives not involved in Starboard's campaign against drugmaker
Former Pfizer CEO, finance chief step back from Starboard's activist campaign
Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D'Amelio Regarding Starboard Value
Why Pfizer Stock Popped Today
Pfizer Declares Fourth-Quarter 2024 Dividend
Pfizer (PFE) Surges Amid Investor Talks and Legal Victory
Pfizer: Investor Activism Is Not The Solution
Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market
Pfizer CEO Bourla to Meet Activist Investor Starboard, Report Says
These 3 Stocks Just Spiked—Buy the Rally or Sell the News?
What's Happening With Pfizer Stock?
As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.